1. Home
  2. ZNB vs ONCO Comparison

ZNB vs ONCO Comparison

Compare ZNB & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

N/A

Current Price

$0.43

Market Cap

2.8M

ML Signal

N/A

Logo Onconetix Inc.

ONCO

Onconetix Inc.

N/A

Current Price

$3.15

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNB
ONCO
Founded
2002
2018
Country
China
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.0M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ZNB
ONCO
Price
$0.43
$3.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.6M
★ 2.6M
Earning Date
10-19-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 22.80
EPS
★ N/A
N/A
Revenue
N/A
★ $815,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.10
$0.09
52 Week High
$9.78
$644.00

Technical Indicators

Market Signals
Indicator
ZNB
ONCO
Relative Strength Index (RSI) 35.09 58.90
Support Level $0.22 $0.56
Resistance Level $1.93 $7.82
Average True Range (ATR) 0.21 0.67
MACD -0.01 0.06
Stochastic Oscillator 6.67 36.87

Price Performance

Historical Comparison
ZNB
ONCO

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group consist principally of cryptocurrency mining. The company conducts business as two operating segments which comprise of consulting services and cryptocurrency mining. Majority of revenue comes from cryptocurrency mining segment.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: